Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870
- 16 August 1996
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 273 (5277) , 969-971
- https://doi.org/10.1126/science.273.5277.969
Abstract
Chagas' disease, a protozoan infection by the kinetoplastid Trypanosoma cruzi, constitutes a major public health problem in Latin America. With the use of mouse models of both short- and long-term forms of the disease, the efficacy of D0870, a bis-triazole derivative, was tested. D0870 was able to prevent death and induced parasitological cure in 70 to 90 percent of animals, in both the short- and long-term disease. In contrast, currently used drugs such as nifurtimox or ketoconazole prolonged survival but did not induce significant curing effects. D0870 may be useful in the treatment of human long-term Chagas' disease, a condition that is currently incurable.Keywords
This publication has 21 references indexed in Scilit:
- Antiproliferative Effects of △24(25) Sterol Methyl Transferase Inhibitors on Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo StudiesChemotherapy, 1996
- Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by Δ24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazoleMolecular and Biochemical Parasitology, 1995
- In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida sppAntimicrobial Agents and Chemotherapy, 1995
- In vitro and in vivo antifungal activities of D0870, a new triazole agentAntimicrobial Agents and Chemotherapy, 1993
- The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruziActa Tropica, 1993
- A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas diseaseMemórias do Instituto Oswaldo Cruz, 1993
- An experimental and clinical assay with ketoconazole in the treatment of Chagas diseaseMemórias do Instituto Oswaldo Cruz, 1993
- The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitroMolecular and Biochemical Parasitology, 1989
- Activity of ICI 195,739—a Novel, Orally Active Bistriazole—in Rodent Models of Fungal and Protozoal InfectionsAnnals of the New York Academy of Sciences, 1988
- Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruziAntimicrobial Agents and Chemotherapy, 1988